In the absence of HCV infection, interferon stimulated gene expression in liver is not associated with IL28B genotype

Gastroenterology

Volumn 139, Issue 4, 2010, Pages 1422-1424

  Shebl, Fatma M ^a   Maeder, Dennis ^a,b   Shao, Yongwu ^c   Prokuninaolsson, Ludmila ^a   Schadt, Eric E ^d,e   O'Brien, Thomas R ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c INFORMATION MANAGEMENT SERVICES INC   (United States)

^d SAGE BIONETWORKS   (United States)

^e PACIFIC BIOSCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; 5' NUCLEOTIDASE; INTERFERON; INTERFERON STIMULATED GENE FACTOR 3; INTERLEUKIN 28; POLYRIBONUCLEOTIDE NUCLEOTIDYLTRANSFERASE; RIBAVIRIN; S ADENOSYLMETHIONINE; SCRAMBLASE; IL28B PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ANTIVIRAL THERAPY; GENE EXPRESSION; GENE FREQUENCY; GENOTYPE; HEPATITIS C; HUMAN; HUMAN TISSUE; LETTER; LIVER; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; DRUG EFFECTS; GENETICS; METABOLISM;

GENE EXPRESSION; GENOTYPE; HUMANS; INTERFERONS; INTERLEUKINS; LIVER;

EID: 77957348326     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.07.055     Document Type: Letter

References (7)

1. M. Sarasin-Filipowicz, E.J. Oakeley, and F.H. Duong Interferon signaling and treatment outcome in chronic hepatitis C Proc Natl Acad Sci U S A 105 2008 7034 7039
2. D. Ge, J. Fellay, A.J. Thompson, and J.S. Simon Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance Nature 461 2009 399 401
3. A. Rauch, Z. Kutalik, and P. Descombes Genetic variation in IL28B Is associated with chronic hepatitis C and treatment failure: a genome-wide association study Gastroenterology 138 2010 1338 1345
4. V. Suppiah, M. Moldovan, and G. Ahlenstiel IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy Nat Genet 41 2009 1100 1104
5. Y. Tanaka, N. Nishida, and M. Sugiyama Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C Nat Genet 41 2009 1105 1109
6. M. Honda, A. Sakai, and T. Yamashita Hepatic ISG expression is associated with genetic variation in IL28B and the outcome of IFN therapy for chronic hepatitis C Gastroenterology 139 2010 499 509
7. E.E. Schadt, C. Molony, and E. Chudin Mapping the genetic architecture of gene expression in human liver PLoS Biol 6 2008 e107